This video clarifies the long-standing diagnostic confusion between Dermal Nerve Sheath Myxoma (DNSM) and Cellular Neurothekeoma (CN), advocating for precise nomenclature to prevent misinterpretation. It details DNSM as a true Schwann cell-origin tumor, histologically characterized by multi-nodular, hypocellular myxoid lobules with fibrous septa, cords of epithelioid cells, and occasional nuclear palisading, consistently staining positive for S100 and Sox10. DNSM has a predilection for distal extremities and a high local recurrence rate, though it is benign.
In contrast, Cellular Neurothekeoma is presented as a non-nerve sheath tumor, typically featuring multi-nodular, cellular areas of plump, histiocytoid cells with pale chromatin, sometimes admixed with myxoid regions, and importantly, is consistently negative for S100 and Sox10. While CN can exhibit significant cellular atypia, mitotic activity, pleomorphism, and multinucleated giant cells, these features are generally not associated with aggressive behavior. CN commonly affects the upper extremities, head, and neck in younger individuals and has a low recurrence rate. The video emphasizes the critical role of immunohistochemistry (S100/Sox10) alongside H&E morphology to accurately distinguish these entities, especially when differentiating atypical CN from melanocytic lesions or sarcomas, thereby avoiding overdiagnosis of malignancy.
Clarifying Dermal Nerve Sheath Myxoma vs. Cellular Neurothekeoma: A Pathological Guide
0:03 - Historical Confusion in Nomenclature: The video highlights decades of confusion between Dermal Nerve Sheath Myxoma (DNSM) and Neurothekeoma, advocating for distinct naming to avoid misdiagnosis, particularly with "Cellular Neurothekeoma."
1:19 - Characteristics of Dermal Nerve Sheath Myxoma (DNSM):
Location & Appearance: Usually found in the dermis, sometimes extending to the subcutis; presents as striking multi-nodular, pale, blue myxoid lobules separated by fibrous septa. It is typically hypocellular.
Cellular Features: Composed of plump, epithelioid cells suspended in a myxoid background, often forming cords, chains, or vague swirling patterns.
Key Diagnostic Clue: May exhibit nuclear palisading, a feature reminiscent of schwannomas.
Immunohistochemistry (IHC): Confirmed as a true nerve sheath tumor of Schwann cell origin by strong positivity for S100 and Sox10, and often GFAP.
Clinical Behavior: Benign, but has a significant local recurrence rate (up to 3-5 times or more) if incompletely excised, especially on distal extremities (hands and fingers) due to anatomical constraints.
5:07 - Introducing Cellular Neurothekeoma (CN) and Key Distinctions:
Low-Power Similarities: Can resemble DNSM at low power with multi-lobular, pale, myxoid areas and fibrous bands.
High-Power Differences: Features cellular, sheet-like areas with larger, more epithelioid or histiocytoid cells. These cells have abundant cytoplasm, large oval-to-round nuclei with fine, delicate, pale chromatin, and sometimes small nucleoli.
Crucial IHC: Unlike DNSM, Cellular Neurothekeoma is consistently negative for S100 and Sox10, indicating it is not a true nerve sheath tumor.
Nature: Believed to be part of the fibrohistiocytic spectrum.
Ancillary Markers (for exams): May show positivity for PGP 9.5, NKI/C3, NSE, and S100A6.
10:07 - Classic Presentation of Cellular Neurothekeoma:
Histology: Displays multi-nodular nests of plump, epithelioid, histiocytoid cells within a dense collagenous or sclerotic background. Cells have open, pale chromatin and sometimes central punctate nucleoli.
Differential Diagnosis: A major risk is misdiagnosing CN as a melanocytic lesion (e.g., Spitz nevus/melanoma) due to the nested, epithelioid cell morphology. S100/Sox10 negativity is essential to rule out melanocytic origin.
Mitotic Activity: Mitoses are often present (average ~3 per 10 high-power fields) and can occasionally be atypical.
Prognostic Insight: Notably, these atypical features and mitotic activity in CN do not correlate with aggressive behavior or poor prognosis.
Location: Always confined to the dermis; epidermal involvement is not characteristic.
17:22 - Additional Clinical & Histologic Aspects of CN:
Unique Feature: Approximately 15% of CN cases contain multinucleated osteoclastic-like giant cells.
Growth Pattern: May exhibit cellular sheet-like areas and infiltrative growth at the edges, which are benign findings.
Demographics: Predominantly affects children and young adults, with a slightly higher incidence in women. Commonly located on the upper extremities (shoulder region) and head/neck.
Recurrence: Has a low risk of local recurrence, unlike DNSM.
19:47 - Mixed Myxoid and Cellular Cellular Neurothekeoma:
Variability: About one-third of CN cases present with a mix of hypocellular myxoid zones and hypercellular areas, historically leading to the "mixed type neurothekeoma" designation.
Current View: These mixed presentations are still classified as Cellular Neurothekeoma, with the myxoid areas potentially serving as a helpful diagnostic clue.
Alarming Features: CN can present with very large, multi-nodular, sharply circumscribed lesions, exhibiting significant pleomorphism, abundant mitotic activity (including atypical forms), and multinucleated tumor giant cells.
Benign Behavior: Despite these histologically alarming features, published studies confirm a benign clinical course.
Diagnostic Caution: Critical to distinguish from malignancies like melanoma or myxofibrosarcoma through S100/Sox10 negativity and the characteristic multi-nodular growth pattern.
Management Recommendation: For highly atypical cases, conservative re-excision and close patient follow-up are advisable due to their rarity and the evolving understanding of this entity.
29:56 - Case Example: Atypical CN with Peripheral Classic Nests:
Confirmation in Atypical Cases: In large, atypical lesions with mixed myxoid/cellular features, finding small, classic nests of histiocytoid cells at the tumor's periphery provides crucial diagnostic reassurance, confirming benign CN and preventing overdiagnosis of malignancy, particularly in young patients.